RVL Pharmaceuticals plc (RVLPQ)
Sells eyedrop treatments for drooping eyelids and cosmetic conditions.
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+0.0%
The outlook
RVLPQ trades near the bottom of its 52-week range, sitting just 2% above its low. The stock is technically above its 50- and 200-day moving averages, suggesting some support at current levels. Analyst coverage appears minimal for this micro-cap stock.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
$1,114
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—